Solventum (NYSE:SOLV) Releases FY 2025 Earnings Guidance

Solventum (NYSE:SOLV) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of 5.450-5.650 for the period, compared to the consensus estimate of 5.490. The company issued revenue guidance of -.

Solventum Trading Down 4.7 %

SOLV opened at $79.56 on Friday. Solventum has a twelve month low of $47.16 and a twelve month high of $96.05. The company has a 50-day simple moving average of $72.51 and a 200 day simple moving average of $69.88. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. The stock has a market capitalization of $13.74 billion and a price-to-earnings ratio of 28.93.

Analyst Ratings Changes

SOLV has been the subject of several recent analyst reports. Morgan Stanley upped their price objective on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Wells Fargo & Company boosted their target price on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday. Mizuho initiated coverage on Solventum in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price objective for the company. Bank of America upped their price objective on Solventum from $80.00 to $85.00 and gave the company a “neutral” rating in a research note on Wednesday. Finally, Piper Sandler upped their price objective on Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $74.71.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.